Permit documentation

ABOUT THE ENTERPRISE
Federal State Unitary Enterprise "Moscow Endocrine Plant." (Hereinafter referred to as the Enterprise) reports to the Ministry of Industry and Trade of the Russian Federation and is one of the key producers of essential and socially important medical products in the country.
The company has a 75-year history of successful activity in the field of development and production of maedical products, from the manufacture of active pharmaceutical ingredients to the production of the finished dosage forms.
FSUE "Moscow Endocrine Plant," today it is - 3 production sites, own departments of scientific and pharmaceutical development, vivarium, accredited testing laboratory and more than 1000 specialists.
The Enterprise is characterized by a high culture of production and provides consumers with quality effective and safe medical products available to consumers regardless of their standard of living and material income.
The assortment portfolio of FSUE "Moscow Endocrine Plant" includes more than 90 types of medical prodcuts, 58 are included in the list of essential and essential medical products approved by the Government of the Russian Federation.
A significant proportion of medical products are analgesics of central action, as well as preparations widely used in ophthalmology, cardiology, gynecology and psycho-neurological practice, preparations of anti-inflammatory and metabolic action and a number of others.
The Enterprise’s products are widely in demand in all regions of Russia and in 12 foreign countries.
INDUSTRIAL POTENTIAL
According to the international classification, FSUE "Moscow Endocrine Plant" belongs to the category of large manufacturers of the pharmaceutical industry.
In 2016, in accordance with the Resolution of the Government of Moscow dated February 11, 2016 No. 38-ПП "On Measures to Implement Industrial Investment Policy in the City of Moscow," the Interdepartmental Commission on Assignment, Confirmation and Termination of Statuses in the Field of Industrial and Investment Activities, the Enterprise was assigned the status "Industrial Complex" and was included into the Register of Investment Priority projects of Moscow.
The industrial potential of the Enterprise is concentrated on the main production site in the central part of Moscow and two branches located in Moscow and the Bryansk region.
The company is equipped with production lines of the world’s leading manufacturers of equipment for pharmaceutical production: GLATT, Romaco Macofar, IMA, CAM, Bosch, Optima, Optrel.
Highly qualified technologists, chemists, engineers, quality specialists, staff the production staff.
The development program of the Enterprise until 2022 is planned to reconstruct existing and build new production areas, develop scientific research and organize a full cycle of production of medicines, including active pharmaceutical ingredients, as well as manufacturing of medical products (individual autoinjectors for intramuscular introduction of medicines, etc.).
Permit documentation
Сертификат соответствия Госстроя, выдается на продукцию, используемую в строительстве, и подтверждающий, что продукция соответствует требованиям основных нормативно-технических документов, установленных для данной продукции при сертификации продукции в строительстве.